A complete metagenome-assembled genome of Acinetobacter pittii ST640, recovered from a human stool-derived mixed culture in ...

FRAMINGHAM, Mass., Dec. 17, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical ...

BASEL, Switzerland, October 28, 2025--(BUSINESS WIRE)--Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and ...

Complete Genomics and Velsera are collaborating to deliver an end-to-end genetic testing solution that integrates DNBSEQ™ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW) data ...

Complete Genomics will share details of various multi-omics and spatial transcriptomics applications based on its sequencing technology at the 2024 American Society of Human Genetics (ASHG) Meeting.

The genomic revolution that began at the end of the 20 th century has given researchers increasingly detailed insights into the organization of DNA and the role of genes in diseases. However, due to ...

Complete Genomics announced that it has agreed to be acquired by Swiss Rockets AG, a Switzerland-based life sciences group, in a transaction subject to customary closing conditions and approval by MGI ...

Differences among the DNA of seven ape species—including humans—are greater than originally thought, according to an international team led by researchers at Penn State, the National Human Genome ...

Entrepreneur, investor and award-winning film producer to join the board upon closing of the company's pending acquisition by Swiss Rockets AG "Complete Genomics is advancing technologies that have ...

The common marmoset is a small monkey from South America. To study complex diseases like Alzheimer’s, scientists and clinicians analyze how genes change and malfunction in other species. Marmosets, a ...

With confidence dropping in doing business with China-affiliated life sciences companies due to the Biosecure Act, one of the companies explicitly named in the U.S. legislation is fighting back.